OTR Therapeutics

#Collaboration #Metabolic diseases #OTR Therapeutics #Zealand Pharma

Zealand and OTR enter strategic collaboration on metabolic therapies

Zealand Pharma and OTR Therapeutics have entered a multi-programme strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases.  The collaboration will combine Zealand Pharma’s experience in obesity and metabolic health with OTR Therapeutics’ oral small-molecule platform.  "The multi-programme collaboration will expand our metabolic health pipeline into oral… Read More

#Business & Investment #News

#Financing #Investment #Neurology #OTR Therapeutics

OTR Therapeutics raises $100 million in series A financing

OTR Therapeutics has emerged from stealth and announced the successful completion of a $100 million Series A financing.   The round was backed by True Light Capital, a wholly-owned subsidiary of Temasek, LAV, Pfizer Ventures, and Sirona Capital.  Founded in March 2025, Shanghai-based OTR Therapeutics aims to discover and acquire… Read More

#Business & Investment #News #Start-up Zone